Gellan sulfate inhibits plasmodium falciparum growth and invasion of red blood cells in vitro

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Recuenco, Frances Cagayat ^a,b   Kobayashi, Kyousuke ^c   Ishiwa, Akiko ^a   Enomoto Rogers, Yukiko ^a   Fundador, Noreen Grace V ^a   Sugi, Tatsuki ^a,b   Takemae, Hitoshi ^a,b   Iwanaga, Tatsuya ^a   Murakoshi, Fumi ^a   Gong, Haiyan ^a   Inomata, Atsuko ^a   Horimoto, Taisuke ^a   Iwata, Tadahisa ^a   Kato, Kentaro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELLAN SULFATE; POLYSACCHARIDE; SULFATE;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; RADIATION EXPOSURE;

ANIMALS; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYSACCHARIDES; SULFURIC ACID ESTERS;

EID: 84898822259     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04723     Document Type: Article

References (60)

1. World Health Organization. World malaria report: 2012. http://www.who.int/malaria/publications/world-malaria-report-2012/ wmr2012-full-report.pdf (2012). Date accessed: March 27, 2014.
2. Kweka, E. J. et al. Challenges to malaria control and success stories in Africa. Glob. Health Perspect. 1, 71-80 (2013).
3. Sherman, I. W. Malaria: Parasite Biology, Pathogenesis and Protection. (ASM Press, 1998).
4. Yahata, K., Treeck, M., Culleton, R., Gilberger, T. W. & Kaneko, O. Time-lapse imaging of red blood cell invasion by the rodent malaria parasite Plasmodium yoelii. PLoS One 7, e50780. (2012).
5. Schwartz, L., Brown, G. V., Genton, B. & Moorthy, V. S. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar. J. 11, (2012).
6. Cowman, A., Berry, D. & Baum, J. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol 198, 961-971 (2012).
7. Gaur, D.&Chitnis, C. E. Molecular interactions and signalingmechanisms during erythrocyte invasion by malaria parasites. Curr. Opin. Microbiol. 14, 422-428 (2011).
8. Harvey, K. L., Gilson, P. R. & Crabb, B. S. A model for the progression of receptorligand interactions during erythrocyte invasion by Plasmodium falciparum. Int. J. Parasitol. 42, 567-573 (2012).
9. Kulane, A. et al. Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro. Am. J. Trop. Med. Hyg. 46, 589-594 (1992).
10. Clark, D. L., Su, S. &Davidson, E. A. Saccharide anions as inhibitors of themalaria parasite. Glycoconjugate J. 14, 473-79 (1997). (Pubitemid 27289442)
11. Xiao, L.,Yang, C., Patterson, P. S., Udhayakumar, V. & Lal, A. A. Sulfated polyanions inhibit invasion of erythrocytes by Plasmodium merozoites and cytoadherence of endothelial cells to parasitized erythrocytes. Infect. Immun. 64, 1373-1378 (1996).
12. Bastos, M. F. et al. Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion. (abstract) Antimicrob Agents Chemother doi: 10.1128/AAC.00686-13 AAC.00686-13 (2014).
13. Andrews, K. T., Klatt, N., Adams, Y., Mischnick, P. & Schwartz-Albiez, R. Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparuminfected erythrocytes by sulfated polysaccharides. Infect. Immun. 73, 4288-4294 (2005). (Pubitemid 40923172)
14. Schwartz-Albiez, R. et al. Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica. Glycoconj J 24, 57-65 (2007). (Pubitemid 44935065)
15. Vogt, A. M. et al. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog 2, e100. doi:10.1371/journal.ppat. 0020100 (2006). (Pubitemid 44525729)
16. Zhang, Y. et al. Proteomic analysis of Plasmodium falciparum schizonts reveals heaparin-binding merozoite proteins. J. Proteome Res. 12, 2185-93 (2013).
17. Kobayashi, K. et al. Analyses of interactions between heparin and the apical surface proteins of Plsamodium falciparum. Sci. Rep. 3, 3178 (2013).
18. Boyle, M. J., Richards, J. S., Gilson, P. R., Chai, W.&Beeson, J.G. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 115, 4559-4568 (2010).
19. Kobayashi, K. et al. Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface. J. Biol. Chem. 285, 1716-1725 (2010).
20. Wilson, D. W., Langer, C., Goodman, C. D., McFadden, G. I. & Beeson, J. G. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob. Agents Ch. 57, 1455-1467 (2013).
21. Lobo, C. A., Rodriguez, M., Reid, M. & Lustigman, S. Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood 101, 4628-4631 (2003). (Pubitemid 36857839)
22. WHO. Guidelines for the Treatment of Malaria-2nd edition (WHO Press, Geneva, 2010).
23. Adams, Y., Smith, S. L., Schwartz-Albiez, R. & Andrews, K. T. Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36. Parasitol. Res. 97, 290-294 (2005). (Pubitemid 41487088)
24. James, M. A. & Alger, N. E. Plasmodium berghei:effect of carrageenan on the course of infection in the A/J mouse. Int. J. Parasitol. 11, 217-220 (1981). (Pubitemid 11006155)
25. Huber, J. D. et al. Blood-brain barrier tight junctions are altered during a 72-h exposure to l-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 283, H1531-H1537 (2002).
26. Yuan, H. et al. Preparation and in vitro antioxidant activity of k-carrageenan oligosaccharides and their oversulfated, acetylated, and phosphorylated derivatives. Carbohydr. Res. 340, 685-692 (2005). (Pubitemid 40260915)
27. Yuan, H., Song, J., Li, X., Li, N. & Dai, J. Immunomodulation and antitumor activity of k-carrageenan oligosaccharides. Cancer Lett. 243, 228-234 (2006). (Pubitemid 44485852)
28. Yuan, H., Song, J., Li, X., Li, N. & Liu, S. Enhanced immunostimulatory and antitumor activity of diferent derivatives of k-carrageenan oligosaccharides from Kappaphycus striatum. J. Appl. Phycol. 23, 59-65 (2011).
29. Wang, F. F. et al. Antibacterial activities of kappa-carrageenan oligosaccharides (abstract). Mechanical Engineering and Materials Science 108, 194-199 (2011).
30. Wang, W. et al. In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus. Antiviral Res. 92, 237-246 (2011).
31. Tang, F., Chen, F. & Li, F. Preparation and potential in vivo anti-influenza virus activity of low molecular-weight k-carrageenans and their derivatives. Journal of Appl. Polymer Sci. 127, 2110-2115 (2013).
32. Vlieghe, P. et al. Synthesis of new covalently bound k-carrageenan-AZT conjugates with improved anti-HIV activities. J. Med. Chem. 45, 1275-1283 (2002). (Pubitemid 34263564)
33. Ogaji, I. J., Nep, E. I. & Audu-Peter, J. D. Advances in natural polymers as pharmaceutical excipients. Pharmaceutica Analytica Acta 3, 146 (2012).
34. Rinaudo, M. & Milas, M. Novel Macromolecules in Food Systems-Developments in Food Science 41 (Elsevier Science B.V., Amsterdam:2000).
35. Shah, J. N., Jani, G. K. & Parikh, J. R. Gellan gum and its applications-a review. Pharmaceutical Information, Articles and Blogs 5, http://www.pharmainfo.net/reviews/gellan-gum-and-its-application-review (2007). Accessed June 10, 2013.
36. Goncalves, V. M. F. et al. Structural analysis of gellans produced by Sphingomonas elodea strains by electrospray tandem mass spectrometry. Carbohydr. Polym. 77, 10-19 (2009).
37. Lee, M. W., Tasi, H. F., Wen, S. M. &Huang, C. H. Photocrosslinkable gellan gum film as an anti-adhesion barrier. Carbohydr Polym 90, 1132-8 (2012).
38. Chang, S. J. et al.Gellan gum films for effective gided bone regeneration. JMed Biol Eng 30, 99-103 (2010).
39. Kim, M. Y., Lee, C. M., Kim, J. N., Cho, K. O. & Lee, K. Y. Prevention of postsurgical peritoneal adhesion in rats using curdlan and gellan gum hydrogels. Macromol Res doi: 10.1007/s13233-012-0184-1 (2012).
40. Silva-Correira, J. et al. Gellan gum-based hydrogels for intervertebral disc tissueengineering applications. J Tissue Eng Regen Med 5, e97-107 (2011).
41. Oliveira, J. T. et al.Gellan gum injectable hydrogels for cartilage tissue engineering applications: in vitro studies and preliminary in vivo evaluation. (abstract) Tissue Eng Part A 16, 343-53 (2010).
42. Miyamoto, K. et al. Preparation of gellan sulfate as an artificial ligand for removal of extra domain A containing fibronectin. Int. J. of Biol. Macromol. 28, 381-385 (2001). (Pubitemid 32377170)
43. Miyamoto, K. et al. Gellan sulfate selectively suppresses the activation of hemocoagulation factors XI and XII. Mater. Sci. Eng. C 30, 364-368 (2010).
44. Jay, A. J. et al. Analysis of structure and function of gellans with different substitution patterns. Carbohydr. Polym. 35, 179-188 (1998). (Pubitemid 128403026)
45. van de Velde, F. et al. H-1 and c-13 high resolution nmr spectroscopy of carrageenans: Application in research and industry. Trends Food Sci. Tech. 13, 73-(2002).
46. van de Velde, F., Pereira, L.&Rollema, H. S. The revised nmr chemical shift data of carrageenans. Carbohydr. Res. 339, 2309-2313 (2004). (Pubitemid 39165122)
47. de Araujo, C. A. et al. Selective sulfation of carrageenans and the influence of sulfate regiochemistry on anticoagulant properties. Carbohydr. Polym. 91, 483-491 (2013).
48. Thahn, T. T. T., Yasunaga, H., Takano, R., Urakawa, H. & Kajiwara, K. Molecular characteristics and gelling properties of carrageenan family-2. Tri-sulfated and tetra-sulfated carrageenans. Polym. Bull. 47, 305-312 (2001). (Pubitemid 33151704)
49. Shih, S., Wang, Z., Guo, S. & Li, L. Anticoagulant activity of cellulose sulfates with different intrinsic viscosities. Asian J. Pharmaceut. Sci. 2, 38-43 (2007).
50. Chen, J. H., Lim, J.D., Sohn, E. H., Cho, Y. S.&Han, E. T. Growth-inhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites. Parasitol. Res. 104, 245-250 (2009).
51. Ono, L. et al. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res. 60, 201-208 (2003). (Pubitemid 37456868)
52. Muschin, T., Kanamoto, T., Nakashima, H. & Yoshida, T. Synthesis and potent biological activities of sulfated galactomannans. Poster presentation: The 9th SPSJ International Polymer Conference (IPC2012) (2012).
53. Bo, S., Muschin, T., Kanamoto, T., Nakashima, H. & Yoshida, T. Sulfation and biological activities of konjac glucomannan. Carbohydr. Polym. 94, 899-903 (2013).
54. Rochas, C., Lahaye, M. & Yaphe, W. Sulfate content of carrageenan and agar determined by infrared spectroscopy. Botanica Marina 29, 335-340 (1986).
55. Melo, M. R. S., Feitosa, J. P. A., Freitas, A. L. P. & dePaula, R. C. M. Isolation and characterization of soluble sulfated polysaccharide from Gracilaria cornea. Carbohydr. Polym. 49, 491-498 (2002). (Pubitemid 34782032)
56. Radfar, A. et al. Synchronous culture of Plasmodium falciparum at high parasitemia levels. Nat. Protoc. 4, 1899-1915 (2009).
57. Persson, K. E. M., Lee, C. T., Marsh, K. & Beeson, J. G. Development and optimization of high-throughput method to measure Plasmodium falciparumspecific growth inhibitory antibodies. J. Clin. Microbiol. 44, 1665-1673 (2006). (Pubitemid 43726253)
58. Bates, A. H.,Mu, J., Jiang, H., Fairhurst, R. M.&Su, X. Use ofmagnetically purified Plasmodium falciparum parasites improves the accuracy of erythrocyte invasion assays. Exp. Parasitol. 126, 278-280. (2010).
59. Spadafora, C., Gerena, L. & Kopydlowski, K. M. Comparison of the in vitro invasive capabilities of Plasmodium falciparum schizonts isolated by Percoll gradient or using magnetic beads separation. Malar. J. 10, (2011).
60. Edmondson, J. M., Armstrong, L. S. & Martinez, A. O. A rapid and simple MTTbased spectrophotometric assay for determining drug sensitivity in monolayer cultures. J. Tissue Cult. Meth. 11, 15-17 (1988).